TradingMenu expanded
Forge Markets Browse Companies
DataMenu expanded
Forge Data IPO Stock Tracker
SolutionsMenu expanded
For Institutions For Shareholders For Investors For Companies In Europe
InsightsMenu expanded
All Insights Blog Reports Videos Webinars
Popular Topics
Buying Pre-IPO Shares Selling Pre-IPO Shares Private Market Reports Private Market Data & Analytics Startup News
AboutMenu expanded
About Us Team Investor Relations People & Culture Careers FAQs
Log In Sign Up
Trading Menu expandedTrading
Forge Markets
Browse Companies
Data Menu expandedData
Forge Data
IPO Stock Tracker
Solutions Menu expandedSolutions
For Institutions
For Shareholders
For Investors
For Companies
In Europe
Insights Menu expandedInsights
All Insights
Blog
Reports
Videos
Webinars
Popular Topics
Buying Pre-IPO Shares
Selling Pre-IPO Shares
Private Market Reports
Private Market Data & Analytics
Startup News
About Menu expandedAbout
About Us
Team
Investor Relations
People & Culture
Careers
FAQs
Trading / Browse Companies / Checkmate Pharmaceuticals Stock

Checkmate Pharmaceuticals Stock

checkmatepharma.comHealthcareFounded: 2015Funding to Date: $82MM

Checkmate Pharmaceuticals is a clinical stage biopharmaceutical company focused on activation of innate immunity to treat cancer.

Learn more about Checkmate Pharmaceuticals IPO
Register for Details

For more details on financing and valuation for Checkmate Pharmaceuticals, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Checkmate Pharmaceuticals.

Register Today

Team

Management Team

Art Krieg MD
Founder, Chief Scientific Officer & Board Member
David Mauro Ph.D
Chief Medical Officer
Karen Brennan
Chief Operations Officer
Kleem Chaudhary Ph.D
Chief Business Officer
James Wooldridge
Chief Medical Officer
Chuck Abdalian
Chief Financial Officer
Barry Labinger
Chief Executive Officer, Board Member & President

Board Members

Art Krieg MD
Keith Flaherty MD
Alan Fuhrman
Michael Powell Ph.D
Sofinnova Investments
Ben Auspitz
F-Prime Capital Partners
Corey Goodman Ph.D
venBio

Other companies like Checkmate Pharmaceuticals in the Healthcare sector

Neuralink
Sector
Healthcare
Last Round Est. Valuation
$2.15B
Colossal Biosciences
Sector
Healthcare
 
 
Altos Labs
Sector
Healthcare
Last Round Est. Valuation
$3.67B
Synchron
Sector
Healthcare
Last Round Est. Valuation
$400.53MM
Grail
Sector
Healthcare
Last Round Est. Valuation
$4.26B
OURA
Sector
Healthcare
 
 
Cytonics
Sector
Healthcare
 
 
Mammoth Biosciences
Sector
Healthcare
Last Round Est. Valuation
$1.08B
Precision Neuroscience
Sector
Healthcare
 
 

News

Globe Newswire 08/07/2020
Checkmate Pharmaceuticals Announces Pricing of Initial Public Offering
CAMBRIDGE, Mass., Aug. 06, 2020 (GLOBE NEWSWIRE) -- Checkmate Pharmaceuticals, Inc. (NASDAQ: CMPI), a clinical stage biotechnology company focused on...
FINSMES 06/10/2020
Checkmate Pharmaceuticals Raises $85M in Series C Financing
Checkmate Pharmaceuticals, a Cambridge, MA-based clinical stage biotechnology company with a novel approach to cancer immunotherapy, completed an $85m Series C financing
Market Screener 10/15/2019
Checkmate Pharmaceuticals : Announces Additions to Management Team

Trending Companies

Frequently Asked Questions